Get Started

IQV

NYSE IQVIA Holdings Inc
Nov 6, 2026 · 12:08 PM ET DELAYED Market Open

$271.50 ↑ +6.62 (+2.50%) Trading Up from the previous close of $264.88, $0.59 below the day’s high of $272.09

YTD change
+20.45%
vs 20-day SMA
+1.17%
vs 200-day SMA
+29.29%

Price ranges

Previous day
$261.00 $267.28
open $267.28 close $264.88
-$2.40 (-0.90%)
Today
$261.20 $272.09
open $262.32 now $271.50
+$9.18 (+3.50%)
Past week
$252.38 $275.06
from $275.06 now $271.50
-$3.56 (-1.29%)
Past month
$252.38 $284.50
from $258.88 now $271.50
+$12.62 (+4.87%)
This year
$154.50 $284.50
from $225.41 now $271.50
+$46.09 (+20.45%)

Price & Performance

+88.41 (+50.10%) / 6M

$152.61$197.99$243.37$288.75May 6Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 4.9% away from all-time highs of $285.61
  • IQV is up 20% since the beginning of the year
  • IQV is up 29% over the past 12 months
  • IQV is up 5% over the past 1 month
  • 2% of all IQV investors are betting against IQV
  • Number of investors short IQV has gone down 7% versus last month

IQV reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +25.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.34
Earnings momentum +6.8% Quarterly EPS growth
Quarterly change +6.8%

Valuation

P/E ratio 32.09
Enterprise value $58.3B
Beta 0.93

Balance sheet & scale

Income$1.4M
Revenue$17.3B
Cash$2.4B
Debt$16.3M
Income / Debt 0.09×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $44.7B

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $902.90 -2.98%
ICLR ICON Plc $201.65 -0.72%
CRL Charles River Laboratories International, Inc. $313.02 -4.07%
IT Gartner, Inc. $198.07 -4.40%
MDGL Madrigal Pharmaceuticals, Inc. $400.10 -0.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.